• Je něco špatně v tomto záznamu ?

Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test

C. Leone, D. Severijns, V. Doležalová, I. Baert, U. Dalgas, A. Romberg, F. Bethoux, B. Gebara, C. Santoyo Medina, H. Maamâgi, K. Rasova, B. Maertens de Noordhout, K. Knuts, A. Skjerbaek, E. Jensen, JM. Wagner, P. Feys,

. 2016 ; 30 (4) : 373-83. [pub] 20150727

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014280

OBJECTIVE: To investigate the individual occurrence of walking-related motor fatigue in persons with multiple sclerosis (PwMS), according to disability level and disease phenotype.Study design This was a cross-sectional, multinational study.Participants They were 208 PwMS from 11 centers with Expanded Disability Status Scale (EDSS) scores up to 6.5. METHODS: The percentage change in distance walked (distance walked index, DWI) was calculated between minute 6 and 1 (DWI(6-1)) of the 6-Minute Walk Test (6MWT). Its magnitude was used to classify participants into 4 subgroups: (1) DWI(6-1)[≥5%], (2) DWI(6-1)[5%; -5%], (3) DWI(6-1)[-5%; > -15%], and (4) DWI(6-1)[≤-15%]. The latter group was labeled as having walking-related motor fatigue. PwMS were stratified into 5 subgroups based on the EDSS (0-2.5, 3-4, 4.5-5.5, 6, 6.5) and 3 subgroups based on MS phenotype (relapsing remitting [RR], primary progressive [PP], and secondary progressive [SP]). RESULTS: The DWI6-1was ≥5% in 16 PwMS (7.7%), between 5% and -5% in 70 PwMS (33.6%), between -5% and -15% in 58 PwMS (24%), and ≤-15% in 64 PwMS (30.8%). The prevalence of walking-related motor fatigue (DWI(6-1)[≤-15%]) was significantly higher among the progressive phenotype (PP = 50% and SP = 39%; RR = 15.6%) and PwMS with higher disability level (EDSS 4.5-5.5 = 48.3%, 6 = 46.3% and 6.5 = 51.5%, compared with EDSS 0-2.5 = 7.8% and 3-4 = 16.7%;P< .05). Stepwise multiple regression analysis indicated that EDSS, but not MS phenotype, explained a significant part of the variance in DWI(6-1)(R(2)= 0.086;P< .001). CONCLUSION: More than one-third of PwMS showed walking-related motor fatigue during the 6MWT, with its prevalence greatest in more disabled persons (up to 51%) and in those with progressive MS phenotype (up to 50%). Identification of walking-related motor fatigue may lead to better-tailored interventions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014280
003      
CZ-PrNML
005      
20170427102333.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1545968315597070 $2 doi
035    __
$a (PubMed)26216790
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Leone, Carmela $u BIOMED, Hasselt University, Hasselt, Belgium Department of Neurosciences GF Ingrassia, University of Catania, Catania carmelaleone84@yahoo.it.
245    10
$a Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test / $c C. Leone, D. Severijns, V. Doležalová, I. Baert, U. Dalgas, A. Romberg, F. Bethoux, B. Gebara, C. Santoyo Medina, H. Maamâgi, K. Rasova, B. Maertens de Noordhout, K. Knuts, A. Skjerbaek, E. Jensen, JM. Wagner, P. Feys,
520    9_
$a OBJECTIVE: To investigate the individual occurrence of walking-related motor fatigue in persons with multiple sclerosis (PwMS), according to disability level and disease phenotype.Study design This was a cross-sectional, multinational study.Participants They were 208 PwMS from 11 centers with Expanded Disability Status Scale (EDSS) scores up to 6.5. METHODS: The percentage change in distance walked (distance walked index, DWI) was calculated between minute 6 and 1 (DWI(6-1)) of the 6-Minute Walk Test (6MWT). Its magnitude was used to classify participants into 4 subgroups: (1) DWI(6-1)[≥5%], (2) DWI(6-1)[5%; -5%], (3) DWI(6-1)[-5%; > -15%], and (4) DWI(6-1)[≤-15%]. The latter group was labeled as having walking-related motor fatigue. PwMS were stratified into 5 subgroups based on the EDSS (0-2.5, 3-4, 4.5-5.5, 6, 6.5) and 3 subgroups based on MS phenotype (relapsing remitting [RR], primary progressive [PP], and secondary progressive [SP]). RESULTS: The DWI6-1was ≥5% in 16 PwMS (7.7%), between 5% and -5% in 70 PwMS (33.6%), between -5% and -15% in 58 PwMS (24%), and ≤-15% in 64 PwMS (30.8%). The prevalence of walking-related motor fatigue (DWI(6-1)[≤-15%]) was significantly higher among the progressive phenotype (PP = 50% and SP = 39%; RR = 15.6%) and PwMS with higher disability level (EDSS 4.5-5.5 = 48.3%, 6 = 46.3% and 6.5 = 51.5%, compared with EDSS 0-2.5 = 7.8% and 3-4 = 16.7%;P< .05). Stepwise multiple regression analysis indicated that EDSS, but not MS phenotype, explained a significant part of the variance in DWI(6-1)(R(2)= 0.086;P< .001). CONCLUSION: More than one-third of PwMS showed walking-related motor fatigue during the 6MWT, with its prevalence greatest in more disabled persons (up to 51%) and in those with progressive MS phenotype (up to 50%). Identification of walking-related motor fatigue may lead to better-tailored interventions.
650    _2
$a dospělí $7 D000328
650    _2
$a průřezové studie $7 D003430
650    _2
$a zátěžový test $7 D005080
650    _2
$a únava $x epidemiologie $x etiologie $x patofyziologie $7 D005221
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a roztroušená skleróza $x komplikace $x epidemiologie $x patofyziologie $7 D009103
650    _2
$a prevalence $7 D015995
650    _2
$a chůze $x fyziologie $7 D016138
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Severijns, Deborah $u BIOMED, Hasselt University, Hasselt, Belgium.
700    1_
$a Doležalová, Vendula $u BIOMED, Hasselt University, Hasselt, Belgium.
700    1_
$a Baert, Ilse $u BIOMED, Hasselt University, Hasselt, Belgium.
700    1_
$a Dalgas, Ulrik $u Department Public Health, Section of Sport Science, Aarhus University, Aarhus, Denmark.
700    1_
$a Romberg, Anders $u Masku Neurological Rehabilitation Center, Masku, Finland.
700    1_
$a Bethoux, Francois $u Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
700    1_
$a Gebara, Benoit $u National MS Center, Melsbroek, Belgium.
700    1_
$a Santoyo Medina, Carmen $u Hospital de Dia de Barcelona CEMCat, Barcelona, Spain.
700    1_
$a Maamâgi, Heigo $u West-Tallinn Central Hospital, Tallinn, Estonia.
700    1_
$a Rasova, Kamila $u Department of Rehabilitation, Third Faculty of Medicine, Charles University in Prague, Czech Republic.
700    1_
$a Maertens de Noordhout, Benoît $u Centre Neurologique et de Réadaptation Fonctionelle Fraiture-en-Condroz, Begium.
700    1_
$a Knuts, Kathy $u Rehabilitation and MS Center, Overpelt, Belgium.
700    1_
$a Skjerbaek, Anders $u MS Hospitals Ry&Haslev, Denmark.
700    1_
$a Jensen, Ellen $u MS Hospitals Ry&Haslev, Denmark.
700    1_
$a Wagner, Joanne M $u Saint Louis University, St. Louis, MO, USA.
700    1_
$a Feys, Peter $u BIOMED, Hasselt University, Hasselt, Belgium.
773    0_
$w MED00180455 $t Neurorehabilitation and neural repair $x 1552-6844 $g Roč. 30, č. 4 (2016), s. 373-83
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26216790 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427102653 $b ABA008
999    __
$a ok $b bmc $g 1200745 $s 975058
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 30 $c 4 $d 373-83 $e 20150727 $i 1552-6844 $m Neurorehabilitation and neural repair $n Neurorehabil Neural Repair $x MED00180455
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace